Literature DB >> 11221951

Revascularization and quality of life for patients with limb-threatening ischemia.

A S Tretinyak1, E S Lee, M M Kuskowski, M P Caldwell, S M Santilli.   

Abstract

Traditional outcomes following revascularization for chronic critical limb ischemia consider limb retention and hemodynamic results. Health-related quality of life is not measured. This study was undertaken to determine if surgery for chronic critical limb ischemia improves health-related quality of life. Forty-six patients undergoing revascularization (anklebrachial index <0.4 for nondiabetics, ankle-brachial index <0.6 for diabetics and rest pain or nonhealing ischemic ulcers) completed pre- and postoperative Short-Form 36 questionnaires, which were used to assess health-related quality of life in patients undergoing arterial reconstruction for chronic critical limb ischemia. Patients reported a mild improvement in functional status postoperatively, and overall low health-related quality of life. Health-related quality of life is slow to show progress following revascularization. Health-related quality of life should become an important outcomes end point.

Entities:  

Mesh:

Year:  2001        PMID: 11221951     DOI: 10.1007/s100160010007

Source DB:  PubMed          Journal:  Ann Vasc Surg        ISSN: 0890-5096            Impact factor:   1.466


  6 in total

1.  Autologous bone marrow mononuclear cell therapy is safe and promotes amputation-free survival in patients with critical limb ischemia.

Authors:  Michael P Murphy; Jeffrey H Lawson; Brian M Rapp; Michael C Dalsing; Janet Klein; Michael G Wilson; Gary D Hutchins; Keith L March
Journal:  J Vasc Surg       Date:  2011-04-22       Impact factor: 4.268

Review 2.  [Patient assessments of quality of life following bypass for chronic critical limb ischaemia].

Authors:  M Engelhardt; W A Wohlgemuth; C Willy; M Tannheimer; K D Wölfle
Journal:  Chirurg       Date:  2009-04       Impact factor: 0.955

Review 3.  A Molecular and Clinical Review of Stem Cell Therapy in Critical Limb Ischemia.

Authors:  Punam P Parikh; Zhao-Jun Liu; Omaida C Velazquez
Journal:  Stem Cells Int       Date:  2017-11-20       Impact factor: 5.443

Review 4.  A systematic review of patient-reported outcome measures patients with chronic limb-threatening ischemia.

Authors:  Philip Goodney; Samir Shah; Yiyuan David Hu; Bjoern Suckow; Scott Kinlay; David G Armstrong; Patrick Geraghty; Megan Patterson; Matthew Menard; Manesh R Patel; Michael S Conte
Journal:  J Vasc Surg       Date:  2022-01-24       Impact factor: 4.860

Review 5.  From bench to bedside: review of gene and cell-based therapies and the slow advancement into phase 3 clinical trials, with a focus on Aastrom's Ixmyelocel-T.

Authors:  Ronnda L Bartel; Erin Booth; Caryn Cramer; Kelly Ledford; Sharon Watling; Frank Zeigler
Journal:  Stem Cell Rev Rep       Date:  2013-06       Impact factor: 5.739

6.  Burden of peripheral arterial disease in Europe and the United States: a patient survey.

Authors:  Elizabeth Marrett; Marco daCosta DiBonaventura; Qiaoyi Zhang
Journal:  Health Qual Life Outcomes       Date:  2013-10-22       Impact factor: 3.186

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.